<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Magazine

Students    Pharmacy Perspectives    Magazine

The Class of 2024 Displays its Resilience Through Annual Story Slam

“Story Slam always sticks out as this event, this kind of seminal event in their pharmacy training, where they really become a unified class.”

Jay Bolan, Senior Academic Coordinator for Experiential Programs, reflects on the annual event typically done in the spring of the P1year. Story Slam is a friendly competition of amateur storytelling in which the audience selects the best story, or storyteller. Each year, the P1 class gathers in one group to each tell 5-minute stories using one of three prompts – How I got here; Confirming Experience; and Do-Over.


Author Jordan Kellerman | Publish Date January 10, 2022
Full Story

Students    Magazine    Pharmacy

Meet the Class of 2025

The class of 2025 are the go-getters. The ones who did not let a pandemic derail their plans. The students who arrived this fall ready to jump in, be flexible, and learn. They came to CU Pharmacy from eight countries, sixteen states, and one U.S. territory. They came to thrive.


Author Jordan Kellerman | Publish Date January 10, 2022
Full Story

School of Pharmacy In the News

NewsMedical

Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants

news outletNewsMedical
Publish DateDecember 28, 2021

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.

Full Story
Health.com

How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

news outletHealth.com
Publish DateDecember 28, 2021

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.

Full Story
The Guardian

Covid pills are ‘very promising’ – but what are the challenges in using them?

news outletThe Guardian
Publish DateDecember 28, 2021

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.

Full Story
Vanguard

US, NGO combat cancer, train 34 Nigerian oncology pharmacists

news outletVanguard
Publish DateDecember 14, 2021

Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.

Full Story